Magnetic targeting with superparamagnetic iron oxide nanoparticles for in vivo glioma

• Main Authors: Fontes de Paula Aguiar Marina, Bustamante Mamani Javier, Klei Felix Taylla, Ferreira dos Reis Rafael, Rodrigues da Silva Helio, Nucci Leopoldo Penteado, Nucci-da-Silva Mariana Penteado, Gamarra Lionel Fernel
• Format: Article
• Language: English
• Published: De Gruyter 2017-10-01
• Series: Nanotechnology Reviews
• Subjects: external magnetic field; glioma; iron oxide; magnetic targeting; tumor
• Online Access: https://doi.org/10.1515/ntrev-2016-0101

The purpose of this study was to review the use of the magnetic targeting technique, characterized by magnetic driving compounds based on superparamagnetic iron oxide nanoparticles (SPIONs), as drug delivery for a specific brain locus in gliomas. We reviewed a process mediated by the application of an external static magnetic field for targeting SPIONs in gliomas. A search of PubMed, Cochrane Library, Scopus, and Web of Science databases identified 228 studies, 23 of which were selected based on inclusion criteria and predetermined exclusion criteria. The articles were analyzed by physicochemical characteristics of SPIONs used, cell types used for tumor induction, characteristics of experimental glioma models, magnetic targeting technical parameters, and analysis method of process efficiency. The study shows the highlights and importance of magnetic targeting to optimize the magnetic targeting process as a therapeutic strategy for gliomas. Regardless of the intensity of the patterned magnetic field, the time of application of the field, and nanoparticle used (commercial or synthesized), all studies showed a vast advantage in the use of magnetic targeting, either alone or in combination with other techniques, for optimized glioma therapy. Therefore, this review elucidates the preclinical and therapeutic applications of magnetic targeting in glioma, an innovative nanobiotechnological method.